Aurinia Pharmaceuticals
AUPH
#5263
Rank
A$1.74 B
Marketcap
$12.79
Share price
0.99%
Change (1 day)
65.20%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): A$17.48 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.23 Billion. , an increase over its 2023 earnings that were of -A$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 A$19.2 M-116.44%
2023 -A$0.12 Billion-31.8%
2022 -A$0.18 Billion-39.4%
2021 -A$0.29 Billion61.9%
2020 -A$0.18 Billion-9.73%
2019 -A$0.2 Billion92.65%
2018 -A$0.11 Billion36.39%
2017 -A$73.59 Million106.29%
2016 -A$35.68 Million-15.4%
2015 -A$42.17 Million65.84%
2014 -A$25.43 Million129.82%
2013 -A$11.07 Million-26.6%
2012 -A$15.08 Million
2010 -A$8.54 Million-39.22%
2009 -A$14.04 Million-43.78%
2008 -A$24.98 Million-53.19%
2007 -A$53.36 Million42.97%
2006 -A$37.32 Million-23.03%
2005 -A$48.49 Million36.1%
2004 -A$35.63 Million172.57%
2003 -A$13.08 Million484.61%
2002 -A$2.24 Million
2000 -A$10.62 Million453.81%
1999 -A$1.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.47 B 38,814.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.58 Million-144.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$34.59 Million-280.09%๐Ÿ‡บ๐Ÿ‡ธ USA